Uses of Gamma Irradiated Amniotic Membrane as an Alternative Method in Psoriasis Treatment

E

Egyptian Atomic Energy Authority

Status

Completed

Conditions

Psoriasis

Treatments

Combination Product: REGE pro

Study type

Interventional

Funder types

Other

Identifiers

NCT03440541
4102017NCRRT

Details and patient eligibility

About

Using of human amniotic membrane extra-cellular matrix as a topical treatment for improving Psoriasis Area and Severity Index (PASI).

Full description

Human amniotic membrane extra-cellular matrix was purchased from National center for radiation research and technology, Egypt, under commercial name REGE pro gel.

Enrollment

22 patients

Sex

All

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

* patients have psoriasis lesion

Exclusion criteria

* must stop other line of treatment

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

22 participants in 1 patient group

treated
Experimental group
Description:
Patients who received patches of REGE pro on psoriasis lesion weekly for 8 weeks
Treatment:
Combination Product: REGE pro

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems